Mumtaz Ali Khan
From: Mumtaz Ali Khan
Mumtaz Ali Khan
Malakand College of Nursing
Subject: Community Health Nursing-II
Topic : Immunization and
Tropical Disease
Prepared by: Mumtaz Ali Khan
CHN-II Unit-II Part-1 BSN 5th Semester
Mumtaz Ali Khan
Objectives
 At the completion of this lecture, students
will be able to:
1) Define Immunization.
2) Overview of Expanded Program for
Immunization (EPI) in Pakistan.
3) Review different types of Immunity.
4) List seven childhood Communicable Diseases
covered by EPI.
5) Explain the types of vaccines.
Mumtaz Ali Khan
Objectives
6) Describe the importance of childhood
immunization in family context.
7) Discuss the process of cold chain.
8) Discuss the responsibilities of a nurse to
maintain cold chain.
9) Discuss the Family/Communities practices
towards immunization.
10) Health Education and Post Vaccination
teaching.
Mumtaz Ali Khan
What is Immunization
 Immunization is derived from a Greek word
‘immune’ means ‘ to be protected ’.
 Immunization, is the process by which an
individual's immune system becomes
stimulated against an agent called antigen.
 Immunization is a process of protecting an
individual from a disease through introduction
of a live , killed or partial component of the
invading organism into the individual system.
Mumtaz Ali Khan
What is Immunization
 Immunization is the process whereby a
person is made immune or resistant to an
infectious disease, typically by the
administration of a vaccine.
 Vaccines stimulate the body’s own immune
system to protect the person against
subsequent infection or disease. (WHO)
 Immunology: The study of the immune
system.
Mumtaz Ali Khan
Expanded Programme on
Immunization (EPI)
 Expanded program on immunization is
mainly designed for delivering vaccines to
children all over the world to control
potential health disorders.
 Established by world health organization
in 1974.
 It is a disease prevention activity aiming at
reducing illness, disability and mortality
from childhood diseases preventable by
immunization.
Mumtaz Ali Khan
Expanded Programme on
Immunization (EPI)
 Expanded program on immunization is
mainly designed for supplying vaccines to
children all over the world to control
potential health disorders.
 To protect children by immunizing them
against childhood tuberculosis, poliomyelitis,
diphtheria, pertussis, tetanus and measles.
 The program also vaccinates pregnant
women with tetanus toxoid vaccine to protect
the new born from neonatal tetanus.
Mumtaz Ali Khan
Expanded Programme on
Immunization (EPI)
 In 1974, the WHO launched its “ Expanded
program of immunization” (EPI) against
six most common preventable diseases:
(Diphtheria, pertussis, tetanus, polio,
tuberculosis, measles and recently added
pneumococcal vaccine).
 (EPI) established by world health
organization in 1974.
Mumtaz Ali Khan
Expanded Programme on
Immunization (EPI) in Pakistan
 In Pakistan it started as pilot / experimental
project in 1978.
 Integrated into regular Health Services 1983.
 It is a disease prevention activity aiming at
reducing illness, disability and mortality from
childhood diseases preventable by
immunization.
 These disease are referred as ‘9’ EPI target
diseases & cause million of illness, disabilities
& death each year.
Mumtaz Ali Khan
Expanded Programme on
Immunization (EPI) in Pakistan
 Later, with the support of development
partners, a number of new vaccines has been
developed.
 For Example:
 Hepatitis B, Haemophilus influenza type b
(Hib) and pneumococcal vaccine (PCV10)
were introduced in 2002, 2009 and 2012, and
inactivated polio vaccine in 2015,
respectively.
Mumtaz Ali Khan
Expanded Programme on
Immunization (EPI) in Pakistan
 It also aims to protect mothers and newborn
against tetanus.
 Immunizing children with these vaccines may
prevent up to 17% of childhood mortality in
Pakistan and help contribute towards
achieving Sustainable Development Goal (US-
SDG) reducing child morbidity and mortality.
 The programme also plans to introduce
rotavirus vaccine in 2017, which will prevent
one cause of fatal diarrhea due to rotavirus.
Mumtaz Ali Khan
International organization in Health
 WHO (World Health Organization).
 UNICEF (United nations international children’s
emergency Fund).
 DFID(Department for international development)
 JICA (Japanese international cooperation agency)
 USAID (United state agency for international
development).
 UNHR (United nation high commission for
refugees).
 GAVI (Global Alliance for vaccine &
immunization).
Mumtaz Ali Khan
Expanded Means?
 Expanding the number of diseases to be
covered.
 Expanding the number of children and target
population to be covered.
 Expanding coverage to all corners of the
country and spreading services to reach the
less privileged sectors of the society.
Mumtaz Ali Khan
‘9’ EPI Target Diseases
1) Poliomyelitis.
2) Neonatal Tetanus.
3) Measles.
4) Diphtheria.
5) Pertussis (Whooping cough).
6) Hepatitis –B.
7) Pneumonia.
8) Tuberculosis.
9) Haemophilus influenzae type b (Hib) +
Meningitis.
Mumtaz Ali Khan
The Objectives of EPI
 To achieve 100% coverage with all EPI
vaccines.
 Eradication of polio to maintain polio free
status.
 Elimination of measles.
 To Reduce Seroprevalence of HBsAg to <
1% among under five.
 Elimination of Neonatal Tetanus.
 To maintain zero level of diphtheria.
Mumtaz Ali Khan
The Objectives of EPI
 Prevention of severe forms of TB ( TB
meningitis & miliary TB).
 To reduce the incidence of whooping cough.
 To Reduce the incidence of Bacteria
Meningitis due to haemophelus influenza.
 To Maintain Immunization Safety.
 Prepare for introduction of new vaccines.
Mumtaz Ali Khan
Strategies of EPI
 Participate vaccination sessions with PHC
services.
 Appropriate measures to expand the
vaccination coverage of the eligible
population.
 Ensuring regular supply of effective vaccine.
 Strengthening the cold chain.
 Training of health personnel.
 Promotion of community participation.
 Incorporating health education activities
related to EPI.
Mumtaz Ali Khan
Targets of EPI
1) Under 5-years children.
2) Women in the child bearing age,
(Reproductive age) (15-45 years).
Mumtaz Ali Khan
Immunization
 Immunization is a process of protecting an
individual from a disease through introduction of
live, or killed or attenuated (weakened) organisms
in the individual system.
 Immunization against vaccine- preventable
diseases is essential to reduce the child mortality,
morbidity and disabilities condition.
 Goals of Immunization:
 Immediate: Prevention of disease in individuals.
 Ultimate: Eradication / elimination of disease
from the world.
Mumtaz Ali Khan
Vaccination versus Immunization
 Vaccination :
 Vaccination is a process of inoculating or
injecting the vaccine / antigen into the body
irrespective of sero conversion.
 Immunization :
 Immunization is the process of inducing
immune response in an individual either
humoral or cell mediated.
Mumtaz Ali Khan
Difference between
Vaccination & Immunization
Mumtaz Ali Khan
Immunizing agents
 Vaccine: Vaccine is an immuno-biological
substance designed to produce specific
protection against a given disease.
 Toxoid: Exotoxins produced by some bacteria
are detoxified and used in the preparation of
vaccine.
 Immunoglobulin: Sterile solution containing
antibodies from human blood.
 Antitoxin or Antisera: Solution of antibodies
derived from the serum of non-human sources.
Mumtaz Ali Khan
Mumtaz Ali Khan
Vaccine preventable diseases
 Vaccine preventable diseases includes: E.g. :
 Poliomyelitis.
 Neonatal Tetanus.
 Measles.
 Diphtheria.
 Pertussis (Whooping Cough).
 Hepatitis-B.
 Childhood Tuberculosis.
 These diseases are preventable and can be
eradicated like Smallpox, as very safe & effective
vaccines are available.
Mumtaz Ali Khan
What is Vaccine
 A vaccine is a immuno-biological
preparation that improves immunity to a
particular disease.
 A vaccine typically contains an agent that
resembles a disease-causing
microorganism, and is often made from
weakened or killed forms of the microbe,
its toxins or one of its surface proteins.
Mumtaz Ali Khan
Types of Vaccines
 Types of vaccines:
1. Live vaccines.
2. Inactivated (killed vaccines).
3. Toxoids.
4. Cellular fraction.
5. Combinations.
Mumtaz Ali Khan
Live attenuated Vaccines
1) Live attenuated vaccines are produced by
modifying a disease-producing virus or
bacteria in a laboratory.
 The resulting vaccine organism retains the
ability to replicate (grow) and produce
immunity, but usually does not cause illness.
 Live attenuated vaccines include BCG, Oral
polio, Measles, Mumps and Rubella, Yellow
fever etc.
Mumtaz Ali Khan
Inactivated / Killed Vaccines
 Organisms are killed or inactivated by heat or
chemicals but remain antigenic.
2) Inactivated vaccines can be composed of
either whole viruses or bacteria, or fractions
of either:
 Fractional vaccines are either protein-based
or polysaccharide-based.
 Protein-based vaccines include toxoids
(inactivated bacterial toxin), and subunit or
subvirion products.
Mumtaz Ali Khan
Inactivated / Killed Vaccines
 Most polysaccharide-based vaccines are
composed of pure cell-wall polysaccharide
from bacteria.
 Inactivated vaccines includes pertussis,
influenza, hepatitis B, Cholera , Rabies
Injectable polio , etc.
 Conjugate polysaccharide vaccines are those
in which the polysaccharide is chemically
linked to a protein.
 This linkage makes the polysaccharide a more
potent / effective vaccine.
Mumtaz Ali Khan
Toxoids Vaccines
 Toxoids Vaccines:
 Certain organism produce exotoxins.
 e.g. diphtheria and tetanus bacilli.
 The toxins produce in these organisms are
detoxicated and used in the preparation of
vaccines.
 The antibody produced neutralize the toxic
moiety produced during infection rather then
act upon the organism.
 These vaccine are safe and effective.
Mumtaz Ali Khan
Cellular Fraction Vaccines
 Cellular Fraction Vaccines:
 Some vaccine are prepared from extracted
cellular fraction,
 e.g. meningococcal, vaccine from the
polysaccharide part of the cell wall, the
pneumococcal vaccine from the
polysaccharide contained in the capsule of
the organism.
 These vaccine are safe and effective.
Mumtaz Ali Khan
Comparison of killed & live vaccine
Characteristics Killed Vaccine Live Vaccine
No of dose Multiple Single
Need for adjuvant Yes No
Duration of
immunity
Shorter Longer
Immunoglobulins
produced
IgG IgA & IgG
Stability at room
temperature
High Low
Mumtaz Ali Khan
Expanded Programme of
Immunization (EPI)
Schedule in Pakistan
Mumtaz Ali Khan
Mumtaz Ali Khan
Mumtaz Ali Khan
Mumtaz Ali Khan
Age of vaccination Type of vaccination Dose Mode of administration
At birth
BCG 0.05 ml right deltoid; intradermal
OPV0 2 drops Oral
6 weeks
OPV-I
Pneumococcal-I
Rotavirus-I
Pentavalent-I
0.5 ml Oral
Front outer side of the thigh
muscle (intramuscular)
OPV1 2 drops Oral
10 weeks Pneumococcal-II
Rotavirus-II
Pentavalent-Il
0.5 ml Front outer side of the thigh
muscle (intramuscular)
OPV-II 2 drops Oral
14 weeks
Pneumococcal-III
IPV I
Pentavalent-III
0.5 ml Front outer side of the thigh
muscle (intramuscular)
OPV-III 2 drops Oral
9 months
MR-I Typhoid
IPV – II
0.5 ml Upper right arm; subcutaneous
15 months
MR-II 0.5ml Upper right arm; subcutaneous
EPI Schedule
Mumtaz Ali Khan
s
AGE VECCINES
to be given
DOSE SITE ROUTE of
administration
At birth BCG
OPV-0
Hep B
0.05 ml
2 drops
0.5 ml
Deltoid
Rt Arm
Oral
Left thigh
Intra dermal
Oral
Intra dermal
At 6 weeks OPV-1
Rota virus -1
Pneumococcal-1
Penta velant-1
2 drops
2 drops
0.5 ml
0.5 ml
Oral
oral
Left thigh
Right thigh
Oral
Oral
I/M
I/M
At 10 weeks OPV-2
Rota virus-2
Pneumococcal-2
Penta velant-2
2 drops
2 drops
0.5 ml
0.5 ml
Oral
oral
Left thigh
Right thigh
Oral
Oral
I/M
I/M
Mumtaz Ali Khan
AGE VECCINES
to be given
DOSE SITE ROUTE of
administration
At 14 weeks OPV-3
IPV
Pneumococcal-3
Penta velant-3
2 drops
0.5 ml
0.5 ml
0.5ml
oral
Left thigh
Left thigh
Right thigh
Oral
i/m
i/m
i/m
At 9 months Measels-1 0.5 ml Left arm subcutaneous
At 15
months
Measles-2 0.5 ml Left arm subcutaneous
Mumtaz Ali Khan
Age of vaccination Type of vaccination Dose Mode of administration
At birth BCG 0.05 ml right deltoid; intradermal
OPV0 2 drops Oral
6 weeks DPT1-HepB1-Hib1 0.5 ml Front outer side of the thigh
muscle (intramuscular)
OPV1 2 drops Oral
10 weeks DPT2-HepB2-Hib2 0.5 ml Front outer side of the thigh
muscle (intramuscular)
OPV2 2 drops Oral
14 weeks DPT3-HepB3-Hib3 0.5 ml Front outer side of the thigh
muscle (intramuscular)
OPV3 2 drops Oral
9 months Measles vaccine-1 0.5 ml Upper right arm;
subcutaneous
15 months
(Booster)
Measles vaccine-2 0.5 ml Upper right arm;
subcutaneous
Mumtaz Ali Khan
EPI Schedule
At Birth
Vaccine Disease Type of
vaccine
Dose Rout of
administration
BCG TB Live
attenuated
variant
0.05 ml intradermal
OPV (0) Polio Live
Attenuated
2 Drops Oral
Mumtaz Ali Khan
EPI Schedule
06- weeks
vaccine Disease Type of Vaccine Dose Rout of vaccine
OPV (1) polio Live attenuated 2 drops Oral
HiB Hib disease Polysaccharide
conjugate
0.5ml IM thigh
HBV Hepatitis B Recombinant,
yeast
Derived HBs
antigen
0.5ml IM thigh
DPT Diphtheria
Pertussis
Tetanus
Toxoid
Toxoid
Killed Pertussis
0.5 IM thigh
Mumtaz Ali Khan
EPI Schedule
10 weeks
Vaccine Disease Type of vaccine Dose Rout of
administration
OPV(2) Polio Live
attenuated
2 drops Oral
HiB Hib
disease
Polysaccharide
conjugate
0.5mal IM thigh
DPT Diphtheria
pertussis
Tetanus
Toxoid
Toxoid
Killed pertussis
0.5ml IM thigh
Mumtaz Ali Khan
EPI Schedule
14 weeks
Vaccine Disease Type of vaccine Dose Rout of
administration
OPV (3) Polio Live attenuated 2 drops Oral
HiB Hib disease Polysaccharide
conjugate
0.5ml IM thigh
HBV Hepatitis B Recombinant,
yeast
Derived HBs
antigen
0.5ml IM thigh
DPT Diphtheria
pertussis
Tetanus
Toxoid
Toxoid
Killed pertussis
0.5ml IM thigh
Mumtaz Ali Khan
09 Month
Vaccine The
Disease
Type of
the
Vaccine
Dose Mode of
administration
Measles Measles All
Live
attenuated
0.5ml Subcutaneous
Mumtaz Ali Khan
15 Month
Vaccine The
Disease
Type of
the
Vaccine
Dose Mode of
administration
MMR Measles
Mumps
German
Measles
All
Live
attenuated
0.5ml Subcutaneous
Mumtaz Ali Khan
Immunization Schedule For Women of
Child Bearing Age
Dose Schedule
TT1 Any time at first contact or as
early as possible during
pregnancy
TT2 One month after the first
visit(TT1)
TT3 Six months after TT2 or during
subsequent pregnancy
TT4 One year after TT3 or during
subsequent pregnancy
TT5 One year after TT4 or during
subsequent pregnancy
Mumtaz Ali Khan
Hazards of Immunization
 No immune response is entirely free from the
risk of adverse reactions or remote squeal.
 The adverse reactions that may occur may be
grouped under the following heads:
1. Reactions inherent to inoculation or injection.
2. Reactions due to faulty techniques.
3. Reactions due to hypersensitivity.
4. Neurological involvement.
5. Inflammatory reactions.
6. Others etc.
Mumtaz Ali Khan
Common side effects of any
vaccine can include:
 Injection site reactions (pain, swelling and
redness).
 Mild fever.
 Shivering.
 Fatigue.
 Headache.
 Muscle and joint pain.
Mumtaz Ali Khan
Contraindications for Vaccines
 In very few conditions, vaccination is
contraindicated.
 All vaccines are contraindicated in those who
have had:
 An anaphylactic reaction to a previous dose.
 Inactivated or killed vaccines are contraindicated
in people with known allergy to vaccines.
 Live vaccines are contraindicated in pregnancy
and in those who are on systemic steroid therapy
or immunosuppressed for any reason.
 Avoid during acute pyretic diseases.
Mumtaz Ali Khan
Action for reactions after
Immunization
 Explain to mother that the reaction after BCG
vaccination should be small lump or papule
which will appear in the third or fourth week,
will form puss in sixth week this is normal.it
should not be touch or scratched.
 Small scar will appear at the end of 10 to12
weeks.
 Explain some of the more common reactions
such as fever, mild swelling and pain at the
vaccination spot.
Mumtaz Ali Khan
Mumtaz Ali Khan
Mumtaz Ali Khan
mumtazkmu@yahoo.com WhatsApp: 0342-9737417
Mumtaz Ali Khan

Unit- (2) Immunization (1) By Mumtaz Ali Khan.pdf

  • 1.
  • 2.
    From: Mumtaz AliKhan Mumtaz Ali Khan
  • 3.
    Malakand College ofNursing Subject: Community Health Nursing-II Topic : Immunization and Tropical Disease Prepared by: Mumtaz Ali Khan CHN-II Unit-II Part-1 BSN 5th Semester Mumtaz Ali Khan
  • 4.
    Objectives  At thecompletion of this lecture, students will be able to: 1) Define Immunization. 2) Overview of Expanded Program for Immunization (EPI) in Pakistan. 3) Review different types of Immunity. 4) List seven childhood Communicable Diseases covered by EPI. 5) Explain the types of vaccines. Mumtaz Ali Khan
  • 5.
    Objectives 6) Describe theimportance of childhood immunization in family context. 7) Discuss the process of cold chain. 8) Discuss the responsibilities of a nurse to maintain cold chain. 9) Discuss the Family/Communities practices towards immunization. 10) Health Education and Post Vaccination teaching. Mumtaz Ali Khan
  • 6.
    What is Immunization Immunization is derived from a Greek word ‘immune’ means ‘ to be protected ’.  Immunization, is the process by which an individual's immune system becomes stimulated against an agent called antigen.  Immunization is a process of protecting an individual from a disease through introduction of a live , killed or partial component of the invading organism into the individual system. Mumtaz Ali Khan
  • 7.
    What is Immunization Immunization is the process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine.  Vaccines stimulate the body’s own immune system to protect the person against subsequent infection or disease. (WHO)  Immunology: The study of the immune system. Mumtaz Ali Khan
  • 8.
    Expanded Programme on Immunization(EPI)  Expanded program on immunization is mainly designed for delivering vaccines to children all over the world to control potential health disorders.  Established by world health organization in 1974.  It is a disease prevention activity aiming at reducing illness, disability and mortality from childhood diseases preventable by immunization. Mumtaz Ali Khan
  • 9.
    Expanded Programme on Immunization(EPI)  Expanded program on immunization is mainly designed for supplying vaccines to children all over the world to control potential health disorders.  To protect children by immunizing them against childhood tuberculosis, poliomyelitis, diphtheria, pertussis, tetanus and measles.  The program also vaccinates pregnant women with tetanus toxoid vaccine to protect the new born from neonatal tetanus. Mumtaz Ali Khan
  • 10.
    Expanded Programme on Immunization(EPI)  In 1974, the WHO launched its “ Expanded program of immunization” (EPI) against six most common preventable diseases: (Diphtheria, pertussis, tetanus, polio, tuberculosis, measles and recently added pneumococcal vaccine).  (EPI) established by world health organization in 1974. Mumtaz Ali Khan
  • 11.
    Expanded Programme on Immunization(EPI) in Pakistan  In Pakistan it started as pilot / experimental project in 1978.  Integrated into regular Health Services 1983.  It is a disease prevention activity aiming at reducing illness, disability and mortality from childhood diseases preventable by immunization.  These disease are referred as ‘9’ EPI target diseases & cause million of illness, disabilities & death each year. Mumtaz Ali Khan
  • 12.
    Expanded Programme on Immunization(EPI) in Pakistan  Later, with the support of development partners, a number of new vaccines has been developed.  For Example:  Hepatitis B, Haemophilus influenza type b (Hib) and pneumococcal vaccine (PCV10) were introduced in 2002, 2009 and 2012, and inactivated polio vaccine in 2015, respectively. Mumtaz Ali Khan
  • 13.
    Expanded Programme on Immunization(EPI) in Pakistan  It also aims to protect mothers and newborn against tetanus.  Immunizing children with these vaccines may prevent up to 17% of childhood mortality in Pakistan and help contribute towards achieving Sustainable Development Goal (US- SDG) reducing child morbidity and mortality.  The programme also plans to introduce rotavirus vaccine in 2017, which will prevent one cause of fatal diarrhea due to rotavirus. Mumtaz Ali Khan
  • 14.
    International organization inHealth  WHO (World Health Organization).  UNICEF (United nations international children’s emergency Fund).  DFID(Department for international development)  JICA (Japanese international cooperation agency)  USAID (United state agency for international development).  UNHR (United nation high commission for refugees).  GAVI (Global Alliance for vaccine & immunization). Mumtaz Ali Khan
  • 15.
    Expanded Means?  Expandingthe number of diseases to be covered.  Expanding the number of children and target population to be covered.  Expanding coverage to all corners of the country and spreading services to reach the less privileged sectors of the society. Mumtaz Ali Khan
  • 16.
    ‘9’ EPI TargetDiseases 1) Poliomyelitis. 2) Neonatal Tetanus. 3) Measles. 4) Diphtheria. 5) Pertussis (Whooping cough). 6) Hepatitis –B. 7) Pneumonia. 8) Tuberculosis. 9) Haemophilus influenzae type b (Hib) + Meningitis. Mumtaz Ali Khan
  • 17.
    The Objectives ofEPI  To achieve 100% coverage with all EPI vaccines.  Eradication of polio to maintain polio free status.  Elimination of measles.  To Reduce Seroprevalence of HBsAg to < 1% among under five.  Elimination of Neonatal Tetanus.  To maintain zero level of diphtheria. Mumtaz Ali Khan
  • 18.
    The Objectives ofEPI  Prevention of severe forms of TB ( TB meningitis & miliary TB).  To reduce the incidence of whooping cough.  To Reduce the incidence of Bacteria Meningitis due to haemophelus influenza.  To Maintain Immunization Safety.  Prepare for introduction of new vaccines. Mumtaz Ali Khan
  • 19.
    Strategies of EPI Participate vaccination sessions with PHC services.  Appropriate measures to expand the vaccination coverage of the eligible population.  Ensuring regular supply of effective vaccine.  Strengthening the cold chain.  Training of health personnel.  Promotion of community participation.  Incorporating health education activities related to EPI. Mumtaz Ali Khan
  • 20.
    Targets of EPI 1)Under 5-years children. 2) Women in the child bearing age, (Reproductive age) (15-45 years). Mumtaz Ali Khan
  • 21.
    Immunization  Immunization isa process of protecting an individual from a disease through introduction of live, or killed or attenuated (weakened) organisms in the individual system.  Immunization against vaccine- preventable diseases is essential to reduce the child mortality, morbidity and disabilities condition.  Goals of Immunization:  Immediate: Prevention of disease in individuals.  Ultimate: Eradication / elimination of disease from the world. Mumtaz Ali Khan
  • 22.
    Vaccination versus Immunization Vaccination :  Vaccination is a process of inoculating or injecting the vaccine / antigen into the body irrespective of sero conversion.  Immunization :  Immunization is the process of inducing immune response in an individual either humoral or cell mediated. Mumtaz Ali Khan
  • 23.
    Difference between Vaccination &Immunization Mumtaz Ali Khan
  • 24.
    Immunizing agents  Vaccine:Vaccine is an immuno-biological substance designed to produce specific protection against a given disease.  Toxoid: Exotoxins produced by some bacteria are detoxified and used in the preparation of vaccine.  Immunoglobulin: Sterile solution containing antibodies from human blood.  Antitoxin or Antisera: Solution of antibodies derived from the serum of non-human sources. Mumtaz Ali Khan
  • 25.
  • 26.
    Vaccine preventable diseases Vaccine preventable diseases includes: E.g. :  Poliomyelitis.  Neonatal Tetanus.  Measles.  Diphtheria.  Pertussis (Whooping Cough).  Hepatitis-B.  Childhood Tuberculosis.  These diseases are preventable and can be eradicated like Smallpox, as very safe & effective vaccines are available. Mumtaz Ali Khan
  • 27.
    What is Vaccine A vaccine is a immuno-biological preparation that improves immunity to a particular disease.  A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Mumtaz Ali Khan
  • 28.
    Types of Vaccines Types of vaccines: 1. Live vaccines. 2. Inactivated (killed vaccines). 3. Toxoids. 4. Cellular fraction. 5. Combinations. Mumtaz Ali Khan
  • 29.
    Live attenuated Vaccines 1)Live attenuated vaccines are produced by modifying a disease-producing virus or bacteria in a laboratory.  The resulting vaccine organism retains the ability to replicate (grow) and produce immunity, but usually does not cause illness.  Live attenuated vaccines include BCG, Oral polio, Measles, Mumps and Rubella, Yellow fever etc. Mumtaz Ali Khan
  • 30.
    Inactivated / KilledVaccines  Organisms are killed or inactivated by heat or chemicals but remain antigenic. 2) Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either:  Fractional vaccines are either protein-based or polysaccharide-based.  Protein-based vaccines include toxoids (inactivated bacterial toxin), and subunit or subvirion products. Mumtaz Ali Khan
  • 31.
    Inactivated / KilledVaccines  Most polysaccharide-based vaccines are composed of pure cell-wall polysaccharide from bacteria.  Inactivated vaccines includes pertussis, influenza, hepatitis B, Cholera , Rabies Injectable polio , etc.  Conjugate polysaccharide vaccines are those in which the polysaccharide is chemically linked to a protein.  This linkage makes the polysaccharide a more potent / effective vaccine. Mumtaz Ali Khan
  • 32.
    Toxoids Vaccines  ToxoidsVaccines:  Certain organism produce exotoxins.  e.g. diphtheria and tetanus bacilli.  The toxins produce in these organisms are detoxicated and used in the preparation of vaccines.  The antibody produced neutralize the toxic moiety produced during infection rather then act upon the organism.  These vaccine are safe and effective. Mumtaz Ali Khan
  • 33.
    Cellular Fraction Vaccines Cellular Fraction Vaccines:  Some vaccine are prepared from extracted cellular fraction,  e.g. meningococcal, vaccine from the polysaccharide part of the cell wall, the pneumococcal vaccine from the polysaccharide contained in the capsule of the organism.  These vaccine are safe and effective. Mumtaz Ali Khan
  • 34.
    Comparison of killed& live vaccine Characteristics Killed Vaccine Live Vaccine No of dose Multiple Single Need for adjuvant Yes No Duration of immunity Shorter Longer Immunoglobulins produced IgG IgA & IgG Stability at room temperature High Low Mumtaz Ali Khan
  • 35.
    Expanded Programme of Immunization(EPI) Schedule in Pakistan Mumtaz Ali Khan
  • 36.
  • 37.
  • 38.
  • 39.
    Age of vaccinationType of vaccination Dose Mode of administration At birth BCG 0.05 ml right deltoid; intradermal OPV0 2 drops Oral 6 weeks OPV-I Pneumococcal-I Rotavirus-I Pentavalent-I 0.5 ml Oral Front outer side of the thigh muscle (intramuscular) OPV1 2 drops Oral 10 weeks Pneumococcal-II Rotavirus-II Pentavalent-Il 0.5 ml Front outer side of the thigh muscle (intramuscular) OPV-II 2 drops Oral 14 weeks Pneumococcal-III IPV I Pentavalent-III 0.5 ml Front outer side of the thigh muscle (intramuscular) OPV-III 2 drops Oral 9 months MR-I Typhoid IPV – II 0.5 ml Upper right arm; subcutaneous 15 months MR-II 0.5ml Upper right arm; subcutaneous EPI Schedule Mumtaz Ali Khan
  • 40.
    s AGE VECCINES to begiven DOSE SITE ROUTE of administration At birth BCG OPV-0 Hep B 0.05 ml 2 drops 0.5 ml Deltoid Rt Arm Oral Left thigh Intra dermal Oral Intra dermal At 6 weeks OPV-1 Rota virus -1 Pneumococcal-1 Penta velant-1 2 drops 2 drops 0.5 ml 0.5 ml Oral oral Left thigh Right thigh Oral Oral I/M I/M At 10 weeks OPV-2 Rota virus-2 Pneumococcal-2 Penta velant-2 2 drops 2 drops 0.5 ml 0.5 ml Oral oral Left thigh Right thigh Oral Oral I/M I/M Mumtaz Ali Khan
  • 41.
    AGE VECCINES to begiven DOSE SITE ROUTE of administration At 14 weeks OPV-3 IPV Pneumococcal-3 Penta velant-3 2 drops 0.5 ml 0.5 ml 0.5ml oral Left thigh Left thigh Right thigh Oral i/m i/m i/m At 9 months Measels-1 0.5 ml Left arm subcutaneous At 15 months Measles-2 0.5 ml Left arm subcutaneous Mumtaz Ali Khan
  • 42.
    Age of vaccinationType of vaccination Dose Mode of administration At birth BCG 0.05 ml right deltoid; intradermal OPV0 2 drops Oral 6 weeks DPT1-HepB1-Hib1 0.5 ml Front outer side of the thigh muscle (intramuscular) OPV1 2 drops Oral 10 weeks DPT2-HepB2-Hib2 0.5 ml Front outer side of the thigh muscle (intramuscular) OPV2 2 drops Oral 14 weeks DPT3-HepB3-Hib3 0.5 ml Front outer side of the thigh muscle (intramuscular) OPV3 2 drops Oral 9 months Measles vaccine-1 0.5 ml Upper right arm; subcutaneous 15 months (Booster) Measles vaccine-2 0.5 ml Upper right arm; subcutaneous Mumtaz Ali Khan
  • 43.
    EPI Schedule At Birth VaccineDisease Type of vaccine Dose Rout of administration BCG TB Live attenuated variant 0.05 ml intradermal OPV (0) Polio Live Attenuated 2 Drops Oral Mumtaz Ali Khan
  • 44.
    EPI Schedule 06- weeks vaccineDisease Type of Vaccine Dose Rout of vaccine OPV (1) polio Live attenuated 2 drops Oral HiB Hib disease Polysaccharide conjugate 0.5ml IM thigh HBV Hepatitis B Recombinant, yeast Derived HBs antigen 0.5ml IM thigh DPT Diphtheria Pertussis Tetanus Toxoid Toxoid Killed Pertussis 0.5 IM thigh Mumtaz Ali Khan
  • 45.
    EPI Schedule 10 weeks VaccineDisease Type of vaccine Dose Rout of administration OPV(2) Polio Live attenuated 2 drops Oral HiB Hib disease Polysaccharide conjugate 0.5mal IM thigh DPT Diphtheria pertussis Tetanus Toxoid Toxoid Killed pertussis 0.5ml IM thigh Mumtaz Ali Khan
  • 46.
    EPI Schedule 14 weeks VaccineDisease Type of vaccine Dose Rout of administration OPV (3) Polio Live attenuated 2 drops Oral HiB Hib disease Polysaccharide conjugate 0.5ml IM thigh HBV Hepatitis B Recombinant, yeast Derived HBs antigen 0.5ml IM thigh DPT Diphtheria pertussis Tetanus Toxoid Toxoid Killed pertussis 0.5ml IM thigh Mumtaz Ali Khan
  • 47.
    09 Month Vaccine The Disease Typeof the Vaccine Dose Mode of administration Measles Measles All Live attenuated 0.5ml Subcutaneous Mumtaz Ali Khan
  • 48.
    15 Month Vaccine The Disease Typeof the Vaccine Dose Mode of administration MMR Measles Mumps German Measles All Live attenuated 0.5ml Subcutaneous Mumtaz Ali Khan
  • 49.
    Immunization Schedule ForWomen of Child Bearing Age Dose Schedule TT1 Any time at first contact or as early as possible during pregnancy TT2 One month after the first visit(TT1) TT3 Six months after TT2 or during subsequent pregnancy TT4 One year after TT3 or during subsequent pregnancy TT5 One year after TT4 or during subsequent pregnancy Mumtaz Ali Khan
  • 50.
    Hazards of Immunization No immune response is entirely free from the risk of adverse reactions or remote squeal.  The adverse reactions that may occur may be grouped under the following heads: 1. Reactions inherent to inoculation or injection. 2. Reactions due to faulty techniques. 3. Reactions due to hypersensitivity. 4. Neurological involvement. 5. Inflammatory reactions. 6. Others etc. Mumtaz Ali Khan
  • 51.
    Common side effectsof any vaccine can include:  Injection site reactions (pain, swelling and redness).  Mild fever.  Shivering.  Fatigue.  Headache.  Muscle and joint pain. Mumtaz Ali Khan
  • 52.
    Contraindications for Vaccines In very few conditions, vaccination is contraindicated.  All vaccines are contraindicated in those who have had:  An anaphylactic reaction to a previous dose.  Inactivated or killed vaccines are contraindicated in people with known allergy to vaccines.  Live vaccines are contraindicated in pregnancy and in those who are on systemic steroid therapy or immunosuppressed for any reason.  Avoid during acute pyretic diseases. Mumtaz Ali Khan
  • 53.
    Action for reactionsafter Immunization  Explain to mother that the reaction after BCG vaccination should be small lump or papule which will appear in the third or fourth week, will form puss in sixth week this is normal.it should not be touch or scratched.  Small scar will appear at the end of 10 to12 weeks.  Explain some of the more common reactions such as fever, mild swelling and pain at the vaccination spot. Mumtaz Ali Khan
  • 54.
  • 55.